TFE3 chimeric proteins are constitutively active transcription factors that induce expression of TFE3 target genes, leading to tRCC development and progression [11, 12]. The gene discussed is TFE3; the disease is renal cell carcinoma associated with Xp11.2 translocations/TFE3 gene fusions.